Biorelevant Dissolution-Permeating Testing and Mechanistic In-Silico Modeling
As more oral drugs approach patent expiry, generic drug developers need faster, more predictive approaches to formulation development.
Join our webinar to discover how dissolution–permeation testing and mechanistic in-silico modelling can help you:
- Better understand formulation performance and oral absorption
- Make faster, more informed formulation decisions
- Identify potential bioequivalence risks earlier
- Reduce development risk before costly clinical studies
Discover how an integrated in vitro and in silico approach can help accelerate generic oral drug development.
Two sessions available:
September 29
11:00 AM EDT US | 3:00 PM IST India
